APA (7th ed.) Citation

Drake, K. M., He, R., McGuire, T. G., & Ndikumana, A. (2022). No Free Launch: At-Risk Entry by Generic Drug Firms. International Journal of the Economics of Business, 29(3), 301. https://doi.org/10.1080/13571516.2022.2132808

Chicago Style (17th ed.) Citation

Drake, Keith M., Robert He, Thomas G. McGuire, and Alice Ndikumana. "No Free Launch: At-Risk Entry by Generic Drug Firms." International Journal of the Economics of Business 29, no. 3 (2022): 301. https://doi.org/10.1080/13571516.2022.2132808.

MLA (9th ed.) Citation

Drake, Keith M., et al. "No Free Launch: At-Risk Entry by Generic Drug Firms." International Journal of the Economics of Business, vol. 29, no. 3, 2022, p. 301, https://doi.org/10.1080/13571516.2022.2132808.